Anthony Mancini
See Remarks at Revolution Medicines, Inc. (RVMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 28SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 58739,765 held (−1%) | $200.00 | $117K | -5.1% |
| Sep 28SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,12139,765 held (−7%) | $200.54 | $626K | -5.4% |
| Sep 22SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,76440,352 held (−4%) | $196.94 | $347K | -3.6% |
| Sep 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 2743,863 held (−0%) | $195.05 | $5K | -2.7% |
| Sep 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,74742,116 held (−4%) | $199.30 | $348K | -4.8% |
| Sep 14SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 6,01953,319 held (−10%) | $203.28 | $1.2M | -6.7% |
| Sep 14SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 5,53047,789 held (−10%) | $204.14 | $1.1M | -7.0% |
| Sep 14SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 2,42045,369 held (−5%) | $205.05 | $496K | -7.5% |
| Sep 14SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,17944,190 held (−3%) | $206.10 | $243K | -7.9% |
| Sep 14SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 30043,890 held (−1%) | $207.17 | $62K | -8.4% |
| Jun 18SEC | RVMDRevolution Medicines, Inc. | Sell | 4,61549,975 held (−8%) | $156.12 | $720K | +21.5% |
| May 28SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 70056,821 held (−1%) | $153.30 | $107K | +23.8% |
| May 28SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 2,00054,821 held (−4%) | $154.06 | $308K | +23.2% |
| May 28SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 42154,400 held (−1%) | $154.82 | $65K | +22.6% |
| Apr 29SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,67155,849 held (−3%) | $131.66 | $220K | +44.1% |
| Apr 29SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,04954,800 held (−2%) | $132.88 | $139K | +42.8% |
| Apr 29SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 40054,400 held (−1%) | $134.34 | $54K | +41.3% |
| Mar 26SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,80090,050 held (−2%) | $93.22 | $168K | +103.6% |
| Mar 26SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,12886,922 held (−3%) | $94.16 | $295K | +101.5% |
| Mar 26SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 21,08665,836 held (−24%) | $95.49 | $2.0M | +98.7% |
| Mar 26SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 11,03654,800 held (−17%) | $96.43 | $1.1M | +96.8% |
| Mar 26SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 40054,400 held (−1%) | $97.21 | $39K | +95.2% |
- Sell
See Remarks Anthony Mancini sold $117K of RVMD at $200.00 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Anthony Mancini sold $626K of RVMD at $200.54 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Anthony Mancini sold $347K of RVMD at $196.94 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Anthony Mancini sold $5K of RVMD at $195.05 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Anthony Mancini sold $348K of RVMD at $199.30 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Anthony Mancini sold $1.2M of RVMD at $203.28 — pre-scheduled 10b5-1 plan sale.